This paper is in the following e-collection/theme issue:

Innovations in Clinical Trials and Research Data Management (83) Vaccination and Immunization in the Digital Age (374) Health Services in Resource-Poor Settings and LMICs (414)

Published on in Vol 23, No 8 (2021): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/28573, first published .
Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study

Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study

Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study

Authors of this article:

Trésor Zola Matuvanga1, 2, 3 Author Orcid Image ;   Ginger Johnson4 Author Orcid Image ;   Ynke Larivière2, 3 Author Orcid Image ;   Emmanuel Esanga Longomo5 Author Orcid Image ;   Junior Matangila1 Author Orcid Image ;   Vivi Maketa1 Author Orcid Image ;   Bruno Lapika6 Author Orcid Image ;   Patrick Mitashi1 Author Orcid Image ;   Paula Mc Kenna7 Author Orcid Image ;   Jessie De Bie2, 3 Author Orcid Image ;   Jean-Pierre Van Geertruyden2 Author Orcid Image ;   Pierre Van Damme3 Author Orcid Image ;   Hypolite Muhindo Mavoko1 Author Orcid Image
Article Authors Cited by (9) Tweetations (3) Metrics

Trésor Zola Matuvanga   1, 2, 3 , MD ;   Ginger Johnson   4 , PhD ;   Ynke Larivière   2, 3 , MPH ;   Emmanuel Esanga Longomo   5 , MD ;   Junior Matangila   1 , PhD ;   Vivi Maketa   1 , PhD ;   Bruno Lapika   6 , PhD ;   Patrick Mitashi   1 , PhD ;   Paula Mc Kenna   7 , MSc ;   Jessie De Bie   2, 3 , PhD ;   Jean-Pierre Van Geertruyden   2 , PhD ;   Pierre Van Damme   3 , PhD ;   Hypolite Muhindo Mavoko   1 , PhD

1 Department of Tropical Medicine, University of Kinshasa, Kinshasa, Congo, the Democratic Republic of the

2 Global Health Institute, University of Antwerp, Antwerp, Belgium

3 Centre for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium

4 Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium

5 Division Provinciale de la Santé de la Province de la Tshuapa, Boende, Congo, the Democratic Republic of the

6 Department of Anthropology, University of Kinshasa, Kinshasa, Congo, the Democratic Republic of the

7 Janssen Pharmaceutica NV, Beerse, Belgium

Corresponding Author:

  • Trésor Zola Matuvanga, MD
  • Department of Tropical Medicine
  • University of Kinshasa
  • Avenue Université numéro 1, Commune de Lemba
  • Kinshasa
  • Congo, the Democratic Republic of the
  • Phone: 243 810046306
  • Email: zola.matuvanga@unikin.ac.cd